Tag: BioHemp International
BioHemp International Acts in Response to SEC and OTC Trading Suspension
NEW YORK – As previously disclosed on July 26th, 2019, the Securities and Exchange Commission ("Commission") announced the temporary suspension, pursuant to Section 12(k)...
Ludlow Research Initiates Coverage on BioHemp International and Assigns ‘Speculative’ Price Target
NEW YORK – BioHemp International, Inc. (OTC: BKIT), (“Company”) announced a research opinion on the company is now available for download.
Report Highlights
- To establish...
